(2R,4S)-4-((tert-Butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 1g

3-(4-Methoxyphenyl)butanoic acid, 98%, 1g

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine, >98.0%(HPLC), 10g

(S)-1-(2-(2-Aminoethoxy)-5-chloropyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidin-6-yl)urea hydrochloride, 98%, 250mg

Ethyl 2-(3-bromophenyl)sulfanylacetate, 5g

1H-Indazol-3-amine, 98%, 25g

3-(tert-Butoxycarbonylamino)-3-methylbutanoic acid, 98.0%, 5g

5-(piperidin-4-yl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine dihydrochloride, 95.0%, 250mg

1-Bromo-2,5-difluoro-3-methylbenzene, 95.0%, 5g

1-(4-Fluorophenyl)-2-phenylethane-1,2-dione, 95.0%, 250mg

1-Biphenyl-3-yl-ethanone, 95.0%, 1g

1-Boc-Piperidine-2,4-dione, 97.0%, 10g

2-methyl-5-(2-methyl-2H-tetrazol-5-yl)aniline, 95.0%, 5g